Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Two Cohort (With and Without Imiglucerase), Multicenter Study to Evaluate Pharmacokinetics, Safety, and Efficacy of Eliglustat in Pediatric Patients With Gaucher Disease Type 1 and Type 3

NCT03485677 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT03485677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03485677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Two Cohort (With and Without Imiglucerase), Multicenter Study to Evaluate Pharmacokinetics, Safety, and Efficacy of Eliglustat in Pediatric Patients With Gaucher Disease Type 1 and Type 3
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
April 11, 2018
Completion date
December 26, 2025
Enrollment
57 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher's disease type i, gaucher's disease type iii